stupor (a state close to unconsciousness) catalepsy (trance seizure with rigid body) ... A 2022 study noted a link between catatonic schizophrenia episodes and substance misuse.

In the Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5), schizophrenia is not categorized into different types. The previous edition (the DSM-4), however, organized ...

The causes of the cognitive symptoms of schizophrenia are multifaceted and not fully understood. “Several factors may contribute, including neurobiological factors, genetic factors, and ...

A schizophrenia care team — often known as a coordinated specialty care (CSC) team — is a coordinated team of individuals who are experts on schizophrenia, such as healthcare professionals, as ...

Schizophrenia is a severe and debilitating psychiatric disorder that involves psychotic symptoms such as hallucinations and delusions, accompanied with regressive behaviour. Schizophrenia exhibits ...

Cobenfy Falls Short as Add-On Therapy for Schizophrenia Compared with placebo, xanomeline/trospium as an add-on to atypical antipsychotics has not reached the threshold for a statistically ...

Other therapies hoping to provide a new way to treat schizophrenia include Boehringer Ingelheim's selective glycine transporter 1 inhibitor iclepertin in phase 3, Newron Pharma's sodium channel ...

I'm Alice Shapiro, and I was diagnosed with paranoid schizophrenia. When you're in the midst of your illness, you have a lot of fear about going out. I did. Sometimes it would take me three ...

Schizophrenia is one of the most misunderstood mental health disorders. Often dismissed as witchcraft or demonic possession, it silently affects hundreds of thousands of people in Kenya.

After decades of stagnation in the drug treatment of schizophrenia, a handful of new therapies have raised hopes of improvement – but one of them has just failed a pair of phase 3 trials.